What are the roles of the major neurotransmitters and their receptors in the human nervous system?

Major Neurotransmitters and Their Receptors in the Human Nervous System

Neurotransmitters function as chemical messengers that amplify, transmit, and convert signals between neurons, playing essential roles in learning, memory, motor control, mood regulation, and pain modulation throughout the central and peripheral nervous systems. 1

Excitatory Neurotransmitters

Glutamate

• Glutamate is the primary excitatory neurotransmitter in the brain, essential for learning and memory processes through excitatory postsynaptic potentials 1
• Acts through ionotropic receptors, particularly NMDA receptors, which mediate fast synaptic transmission and are critical for central sensitization in chronic pain states 1
• In chronic pain conditions, enhanced glutamate release at the spinal dorsal horn sensitizes postsynaptic neurons, contributing to pathological pain amplification 2
• Glutamate dominates in the mature brain as a fast-switching neurotransmitter, appearing later in both evolution and ontogeny 3

Acetylcholine

• Acetylcholine serves as the primary neurotransmitter at neuromuscular junctions and plays crucial roles in memory, learning, and autonomic nervous system functions 1
• Functions as a quaternary amine with both central and peripheral nervous system actions 4

Inhibitory Neurotransmitters

GABA (Gamma-Aminobutyric Acid)

• GABA is the major inhibitory neurotransmitter in the CNS, counterbalancing glutamate's excitatory effects 5
• A balance between glutamate and GABA transmission is essential for normal brain function 5
• In chronic pain states, loss of GABAergic interneurons at the spinal cord level contributes to decreased inhibitory control and pain amplification 2
• GABA exhibits developmental plasticity, being excitatory in embryos but inhibitory after birth due to changes in neuronal chloride content 3

Monoamine Neurotransmitters

Dopamine

• Dopamine is essential for reward processing, motor control, and motivation, with dysregulation linked to Parkinson's disease, addiction, and schizophrenia 1
• In TA₁ receptor knockout mice, elevated dopamine levels in the dorsal striatum and increased D₂ receptor expression were observed, along with enhanced firing of dopaminergic neurons in the ventral tegmental area 2
• Functions as a primary amine with modulatory roles across multiple neuronal circuits 5, 4

Norepinephrine (Noradrenaline)

• Noradrenergic reuptake inhibition is the main mechanism for controlling visceral pain through descending inhibitory pathways 1
• Norepinephrine is essential for fetal survival, as demonstrated by fatal outcomes in dopamine β-hydroxylase gene knockout studies 3
• Modulates pain transmission in thalamic synaptosomes and participates in descending pain control from the locus coeruleus 2

Serotonin (5-HT)

• Serotonin is critical for mood regulation, sleep cycles, and pain modulation, playing a key role in descending pain inhibitory pathways 1
• 5-HT is a major neurotransmitter in the gut-brain axis, with alterations contributing to irritable bowel syndrome pathophysiology 2
• Functions as an indoleamine with modulatory effects across numerous neuronal circuits 5, 4
• Medications targeting serotonin and norepinephrine (SNRIs) are effective for pain control by enhancing natural pain inhibition pathways 1

Trace Amines

• β-Phenylethylamine (β-PEA) and tyramine act through TA₁ receptors coupled to Gαs, leading to intracellular cAMP accumulation 2
• TA₁ receptors modulate monoaminergic neurotransmission by affecting dopamine, serotonin, and norepinephrine transporters 2
• β-PEA has been associated with mood regulation, though specific mechanisms remain under investigation 2

Neuropeptides

Substance P (SP)

• Substance P is a neuropeptide involved in pain transmission and inflammatory responses 1
• In chronic pain states, increased SP release at the spinal dorsal horn sensitizes postsynaptic neurons and activates glial cells toward neuroinflammatory states 2
• SP and its receptor (SPR) expression in the colon correlates with visceral hypersensitivity in irritable bowel syndrome 2

Calcitonin Gene-Related Peptide (CGRP)

• CGRP and its receptors are enriched in dorsal root ganglia and correlate with visceral hypersensitivity 2
• Enhanced CGRP release contributes to peripheral sensitization and chronic pain amplification 2

Neuropeptide Y (NPY)

• NPY is a major neurotransmitter in the enteric plexus, affecting cholinergic transmission and regulating stress and mood through hippocampal and hypothalamic actions 2

Opioid Peptides

• Endorphins, enkephalins, and dynorphins bind to opioid receptors and modulate pain perception 1

Non-Classical Neurotransmitters

Adenosine and ATP

• ATP functions as both an energy source and signaling molecule in nociceptive pathways 1
• Adenosine suppresses fetal respiration, as demonstrated by pharmacological blocking studies 3

Nitric Oxide (NO)

• Nitric oxide is a diffusible gas neurotransmitter involved in vasodilation and nociceptive processes 1

Brain-Derived Neurotrophic Factor (BDNF)

• BDNF is a key molecular factor contributing to adult neurogenesis, with chronic pain reducing BDNF levels in the ventral tegmental area 2
• Reduced hippocampal neurogenesis associated with chronic pain is TNF-α dependent 2

Receptor Signaling Mechanisms

Ionotropic Receptors

• NMDA receptors for glutamate mediate fast synaptic transmission and are pivotal in spinal cord central sensitization 1
• Hyperphosphorylation of spinal cord NMDAR contributes to chronic visceral hypersensitivity, which can be inhibited by electroacupuncture 2

Metabotropic Receptors

• TA₁ receptors couple to Gαs, producing cAMP accumulation, and can also couple to G₁₆ to increase intracellular calcium 2
• Receptor tyrosine kinases directly or indirectly enhance presynaptic activity by opening cation channels or activating transcriptional factors in dorsal root ganglia 2

Clinical Implications and Therapeutic Targets

Neurological and Psychiatric Disorders

• Many medications target neurotransmitter systems: SSRIs for depression, dopamine precursors for Parkinson's disease, and GABAergic drugs for anxiety and epilepsy 1
• Dysregulation of neurotransmitter systems is linked to specific neurological disorders, though recent evidence shows each system may contribute to multiple conditions 6

Pain Management

• SNRIs enhance descending pain inhibition by targeting both serotonin and norepinephrine reuptake 1
• Electroacupuncture modulates multiple neurotransmitter systems (5-HT, CGRP, NPY) to restore gut-brain axis balance and decrease inflammatory mediators like IL-18 2

Diagnostic Applications

• Advanced neuroimaging techniques like PET can visualize neurotransmitter receptor binding in various neurological conditions 1

Important Clinical Caveats

• Neurotransmitters appear in embryos before neuronal differentiation, potentially serving as morphogens and growth factors rather than solely as chemical messengers during development 3
• Neurotransmitter effects can change during development, such as GABA's switch from excitatory to inhibitory function, which may be crucial for neuronal network wiring 3
• Chronic pain involves both neuronal and glial cell activation, with astrocytes and microglia becoming activated and contributing to neuroinflammatory states 2
• Reduced hippocampal neurogenesis and volume are shared features of both chronic pain and major depressive disorder, suggesting common pathophysiological mechanisms 2